SC1-PM-09-2016
SC1-PM-09-2016
13 projects · €74,150,773 total EU contribution (project-level) · 158 participating organizations · 21 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€74,150,773
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (30)
- Spain (18)
- Italy (16)
- France (14)
- Netherlands (14)
- UK (14)
- BE (11)
- SE (6)
- CH (5)
- DK (5)
- FI (4)
- US (4)
- AT (3)
- CZ (3)
- IE (2)
- LU (2)
- PL (2)
- ZA (2)
- CA (1)
- NO (1)
- PT (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS4 projects · FR
- ECRIN4 projects · FR
- KU Leuven3 projects · BE
- UNIVERSITY COLLEGE LONDON3 projects · UK
- AZM2 projects · NL
- UNIBO2 projects · IT
- ARTTIC2 projects · FR
- UT2 projects · DE
- ECPC2 projects · BE
- EF CLIF2 projects · ES
- IDIBAPS-CERCA2 projects · ES
- VHIR2 projects · ES
Projects
Page 1 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
AnTBiotic – progressing TB drug candidates to clinical proof of concept anTBiotic · 733079 | H2020 | €5,819,416 | €1,242,417 | Details |
Transcranial brain stimulation as innovative therapy for chronic pediatric neuropsychiatric disorder – STIPED STIPED · 731827 | H2020 | €6,195,231 | €262,031 | Details |
EURopean Endeavour for Chimeric Antigen Receptor Therapies EURE-CART · 733297 | H2020 | €5,903,146 | €163,125 | Details |
Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’: A Randomized Controlled Multicentre Trial PAPA-ARTIS · 733203 | H2020 | €5,913,923 | €161,704 | Details |
Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer IMMUNOSABR · 733008 | H2020 | €5,994,176 | €115,175 | Details |
Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery TreatER · 732386 | H2020 | €5,971,174 | €2,643,026 | Details |
Clinical validation of miniature wearable dialysis machine WEAKID · 733169 | H2020 | €3,306,750 | €597,250 | Details |
A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer IMMUNISA · 731623 | H2020 | €6,000,000 | €1,653,010 | Details |
SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS LIVERHOPE · 731875 | H2020 | €5,998,800 | €50,100 | Details |
The artificial pancreas in children aged 1 to 7 years with type 1 diabetes KidsAP · 731560 | H2020 | €4,637,478 | €325,459 | Details |